15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 11 firms covering Xylem Inc, 8 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $133.00 to $168.00, so the covering firms are broadly aligned. The average target of $151.40 sits 21% above the current $125.01. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 7 to 8 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.46 next quarter toward $6.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS11 ratings
Moderate Buy
Strong Buy00%
Buy873%
Hold327%
Sell00%
Strong Sell00%
Based on 11 analysts giving stock ratings to Xylem Inc.
As of Jul, 8 of 11 firms rate XYL a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
XYL EPS & revenue forecast
EPS · NEXT QUARTER
$1.46
Range $1.40 – $1.50 · 19 analysts · +7% YoY
Next period, 19 analysts expect Xylem Inc to earn $1.46 a share (range $1.40 – $1.50), versus $1.37 a year earlier. Full-year consensus is $5.54, growing to $6.10 the year after.
REVENUE · NEXT QUARTER
$2.3B
Range $2.2B – $2.4B · 19 analysts · +2% YoY
Revenue is expected to reach $2.3B (range $2.2B – $2.4B), +2.2% year-over-year. Full-year consensus is $9.3B, rising to $9.6B next year.
Top analysts covering Xylem Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XYL.
#1
Joshua Spector
UBS · Rank #48
Hold
$129.00+3.2% to target
Overall win rate
50%
+ Follow
#2
Nathan Jones
Stifel · Rank #102
Buy
$157.00+25.6% to target
Overall win rate
49%
+ Follow
#3
Andrew Kaplowitz
Citigroup · Rank #143
Buy
$168.00+34.4% to target
Overall win rate
43%
+ Follow
#4
Deane Dray
RBC Capital · Rank #280
Buy
$159.00+27.2% to target
Overall win rate
34%
+ Follow
#5
WG
William Grippin
Barclays
Buy
$154.00+23.2% to target
Coverage
—
+ Follow
XYL stock forecast FAQ
What is XYL's average 12-month price target?+
The 10 analysts with a live target average $151.40 for Xylem Inc over the next 12 months, ranging from a $168.00 high to a $133.00 low.
Is XYL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 11 analyst ratings, 8 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for XYL?+
The Street-high target is $168.00 (Citigroup), and the Street-low is $133.00 (UBS). The average of all 10 active targets is $151.40.
How many Wall Street analysts cover XYL?+
11 analysts have an active rating on Xylem Inc, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering XYL?+
Among analysts who currently cover XYL, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #48). Their current call is Hold with a $129.00 target.
What is Xylem Inc's projected EPS for next quarter?+
The consensus estimate is $1.46 per share (range $1.40 – $1.50) across 19 analysts. Full-year EPS is projected at $5.54, rising to $6.10 the following year.
How much revenue is Xylem Inc expected to report next quarter?+
Consensus revenue is $2.3B (range $2.2B – $2.4B). Full-year revenue is projected at $9.3B, growing to $9.6B next year.
Have analysts been upgrading or downgrading XYL lately?+
As of Jul, 8 of 11 firms rate XYL a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XYL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
